Effects of Cell-Based Angiogenic Gene Therapy at 6 Months: Persistent Angiogenesis and Absence of Oncogenicity

Annals of Thoracic Surgery

Volumn 83, Issue 2, 2007, Pages 640-646

  Kim, Christopher ^a   Li, Ren Ke ^a   Li, Guangming ^a   Zhang, Yaoguang ^a   Weisel, Richard D ^a   Yau, Terrence M ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANGIOGENIC GENE THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL DENSITY; BLOOD VESSEL PARAMETERS; CARCINOGENICITY; CELL BASED GENE THERAPY; CELL TYPE; COLD INJURY; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; GENETIC TRANSFECTION; HEART CELL CULTURE; HEART INJURY; HEART MUSCLE CELL; HEART TRANSPLANTATION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR; SMOOTH MUSCLE FIBER;

ANIMALS; BLOOD VESSELS; CELLS, CULTURED; CICATRIX; FEMALE; FREEZING; GENE THERAPY; HEART INJURIES; MALE; MUSCLE, SKELETAL; MYOBLASTS; MYOCARDIUM; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, INBRED LEW; TIME FACTORS; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846353976     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.09.044     Document Type: Article

References (24)

1. Zibaitis A., Greentree D., Ma F., Marelli D., Duong M., and Chiu R.C. Myocardial regeneration with satellite cell implantation. Transplant Proc 26 (1994) 3294
2. Van Meter Jr. C.H., Claycomb W.C., Delcarpio J.B., et al. Myoblast transplantation in the porcine model: a potential technique for myocardial repair. J Thorac Cardiovasc Surg 110 (1995) 1442-1448
3. Li R.K., Jia Z.Q., Weisel R.D., et al. Cardiomyocyte transplantation improves heart function. Ann Thorac Surg 62 (1996) 654-660
4. Li R.K., Weisel R.D., Mickle D.A., et al. Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J Thorac Cardiovasc Surg 119 (2000) 62-68
5. Yau T.M., Tomita S., Weisel R.D., et al. Beneficial effect of autologous cell transplantation on infarcted heart function: comparison between bone marrow stromal cells and heart cells. Ann Thorac Surg 75 (2003) 169-176
6. Yoo K.J., Li R.K., Weisel R.D., et al. Heart cell transplantation improves heart function in dilated cardiomyopathic hamsters. Circulation 102 Suppl 3 (2000) 204-209
7. Kim E.J., Li R.K., Weisel R.D., et al. Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg 122 (2001) 963-971
8. Yau T.M., Fung K., Weisel R.D., Fujii T., Mickle D.A., and Li R.K. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation 104 Suppl 1 (2001) 218-222
9. Yau T.M., Li G., Weisel R.D., et al. Vascular endothelial growth factor transgene expression in cell-transplanted hearts. J Thorac Cardiovasc Surg 127 (2004) 1180-1187
10. Yau T.M., Li G., Zhang Y., Weisel R.D., Mickle D.A., and Li R.K. Vascular endothelial growth factor receptor upregulation in response to cell-based angiogenic gene therapy. Ann Thorac Surg 79 (2005) 2056-2063
11. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., and Blau H.M. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 22 (2000) 898-901
12. Rosenblatt J.D., Lunt A.I., Parry D.J., and Partridge T.A. Culturing satellite cells from living single muscle fiber explants. In Vitro Cell Dev Biol Anim 31 (1995) 773-779
13. Laham R.J., Sellke F.W., Edelman E.R., et al. Local perivasclar delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100 (1999) 1865-1871
14. Ruel M., Laham R.J., Parker J.A., et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovas Surg 124 (2002) 28-34
15. Rosengart T.K., Lee L.Y., Patel S.R., et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 100 (1999) 468-474
16. Rosengart T.K., Lee L.Y., Patel S.R., et al. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA. Ann Surg 230 (1999) 466-470
17. Menasche P., Hagege A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41 (2003) 1084-1086
18. Fedak P.W., Altamentova S.M., Weisel R.D., et al. Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3. Am J Physiol 284 (2003) H626-H634
19. Yau T.M., Kim C., Ng D., et al. Increasing transplanted cell survival with cell-based angiogenic gene therapy. Ann Thorac Surg 80 (2005) 1779-1786
20. Liu T.B., Fedak P.W., Weisel R.D., et al. Enhanced IGF-1 expression improves smooth muscle cell engraftment after cell transplantation. Am J Physiol 287 (2004) H2840-H2849
21. Yau T.M., Kim C., Li G., Zhang Y., Weisel R.D., and Li R.K. Maximizing ventricular function with multimodal cell-based gene therapy. Circulation 112 Suppl 1 (2005) 123-128
22. Husnain H.K.h., Ye L., Jiang S., et al. Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor. J Mol Med 82 (2004) 539-549
23. Arbiser J.L., Larsson H., Claesson-Welsh L., et al. Overexpression of VEGF 121 in immortalized endothelial cells causes conversion to slowly growing angiosarcoma and high level expression of the VEGF receptors VEGFR-1 and VEGFR-2 in vivo. Am J Pathol 156 (2000) 1469-1476
24. Suzuki K., Murtuza B., Smolenski R.T., et al. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation 104 Suppl 1 (2001) 207-212